DANISH patients will be able to access medical cannabis for another four years after politicians agreed to extend a nationwide trial.
And, companies in the...
PRESS RELEASE
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...